Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 11573677.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malignant hyperthermia (MH) is a potentially fatal pharmacogenetic disease triggered by several anaesthetic agents. The in vitro muscle contracture test (IVCT) is the standard test to establish an individual's risk of susceptibility to MH. Clinical practitioners and geneticists of the European MH Group have agreed on the present guidelines for the detection of MH susceptibility using molecular genetic techniques and/or IVCT to predict the risk of MH.
Medical subject headings
- Genetic Testing
- Malignant Hyperthermia